Form 4: Adial Pharmaceuticals Insider Buys Shares
Insider Transaction (Form 4)
Coastlands Capital LP reported changes in beneficial ownership of Adial Pharmaceuticals, Inc. common stock on July 9, 2026.
Summary
- Open-market purchase: acquired 10,053 Common Stock at $2.79 ($28,048) on July 9, 2026; holds 383,375 after (Indirect).
- Open-market purchase: acquired 1,700 Common Stock at $2.70 ($4,590) on July 10, 2026; holds 385,075 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $32,638, committing personal capital to the stock.
Insider Transactions
Coastlands Capital LP — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-09 | Open-market purchase | Common Stock | 10,053 | $3 | $28.0K | 383,375 |
| 2026-07-10 | Open-market purchase | Common Stock | 1,700 | $3 | $4.6K | 385,075 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-09 | Open-market purchase (10,053 shares) |
| 2026-07-10 | Open-market purchase (1,700 shares) |
Keywords
insider transaction, Form 4, ADIL, ADIAL PHARMACEUTICALS, INC., bullish, Coastlands Capital LP
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.